PlainPill

Growth Hormone

People mainly take Growth Hormone for performance, recovery. Based on 10 first-hand reports and 468 meta-analyses & systematic reviews in the medical literature. Ranked #475 of 1,974 overall.

27
User score
Mostly positive
40% positive0% mixed0% negative60% unclear

Of reports that state an outcome, 100% are positive.

Clinical research
AStrong research base
468
meta-analyses
2,548
RCTs
63,979
papers

What Growth Hormone does, according to users

Of the people who reported each effect, the share who said it got better.

1 more with fewer than 3 reports
betterno changeworse

What the research says

Systematic reviews and meta-analyses from PubMed, with their published conclusions.

AStrong research base

3+ meta-analyses or systematic reviews and 10+ randomized controlled trials in humans. The grade measures how much human research exists — read the conclusions below for what it found.

Pharmacol Res · 2023 · Meta-analysis / systematic review
Efficacy, safety, quality of life, adherence and cost-effectiveness of long-acting growth hormone replacement therapy compared to daily growth hormone in children with growth hormone deficiency: A systematic review and meta-analysis

Conclusion: Adherence and QoL should be addressed from real-world data studies for both the mid and long term and in a larger population. Cost-effectiveness studies are needed to measure the economic impact of LAGH from the healthcare payer's perspective.

PubMed 37236413 ↗
Sci Rep · 2024 · Meta-analysis / systematic review
Long-acting growth hormone in the treatment of growth hormone deficiency in children: a systematic literature review and network meta-analysis

Conclusion: PEG-LAGH (risk ratio [RR]: 1.00, 95% CrI: 0.82, 1.2) reduced the risk of adverse events compared with other LAGH (somatrogon, RR: 1.1, 95% CrI: 0.98, 1.2; somapacitan, RR: 1.1, 95% CrI: 0.96, 1.4; lonapegsomatropin, RR, 1.1, 95% CrI: 0.91, 1.3) and was comparable with DGH. This is the first study to indirectly compare the LAGH thorough a network meta-analysis and provide evidence of the optimal efficacy of various LAGH specifically PEG-LAGH and acceptable safety profile in prepubertal children with GHD.

PubMed 38580693 ↗
Endocrine · 2024 · Meta-analysis / systematic review
Epidemiology of growth hormone deficiency in children and adolescents: a systematic review

Conclusion: The included studies are mostly European, so the provided estimates cannot be considered global. International multicentre studies are needed to compare epidemiological estimates of GHD among different ethnical groups. Considering the considerable cost of human recombinant GH, the only available therapy to treat GHD, understanding accurate epidemiological estimates of GHD in each country is fundamental for resource allocation.

PubMed 38498128 ↗

Dosage people report

As stated by users — not a recommendation. Follow the label or your doctor.

5-8 iumonthly
continuousas reported
4 iudaily
5-6 IUdaily
2x dailyas reported

Reported side effects

How often each side effect came up across all reports.

No side effects reported so far.

What users say

Verbatim quotes, shortened only — each links to the original discussion.

“Living in Thailand I can "buy" GH 5-8iu monthly doses for around $300.”
Source discussion ↗
“GH 6/10 - not really a fat burner but is at the same time, will help you stay lean during off season, basically burns free calories at night if your in a fat oxidative mode”
Source discussion ↗
“Test and GH and busting your ass in the gym consistently.”
Source discussion ↗
“now GH...Today I'm sitting at 207lbs but with a jacked-ish physique to show for it.”
Source discussion ↗
“Currently running 250 Test, 10mg Reta, 6iu GH and 50mg Var. Just started this stack but I love it.”
Source discussion ↗
Top discussions (5)

Other options for performance

User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 2, 2026. How we rate